Prenatal intake of magnesium may harm fetal bones, FDA warns

05/31/2013 |

Clinicians should not give pregnant women magnesium sulfate for more than five to seven days due to reports claiming reduced calcium levels and bone abnormalities in babies, the FDA warned on Thursday. Off-label uses of the drug include the prevention of preterm labor as well as seizures during pregnancy, but officials said the labeling would be changed to emphasize that the medication is not indicated for preventing preterm labor.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
Boise, ID